Location History:
- Mendon, MA (US) (1994 - 2002)
- Bolton, MA (US) (2006 - 2011)
Company Filing History:
2 out of 12 
2 out of 11 
1 out of 1 
Years Active: 1994-2011
Title: Edward S. Cole: Innovator in Transgenic Technology
Introduction
Edward S. Cole is a notable inventor based in Bolton, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of transgenic products. With a total of 6 patents, his work has had a profound impact on medical treatments and therapies.
Latest Patents
One of his latest patents is focused on transgenically produced human Antithrombin III (tgATIII). This invention highlights a unique monosaccharide composition that includes N-acetylgalactosamine (GalNAc), fucose, N-acetylglucosamine, galactose, mannose, and N-acetylneuraminic acid/N-glycolyneuraminic acid. The composition of tgATIII differs from that of plasma-derived ATIII (phATIII), and it has been found to have an increased clearance rate compared to phATIII. Another significant patent involves treatments using transgenic goat-produced antithrombin III, further emphasizing the innovative approaches he has taken in his research.
Career Highlights
Throughout his career, Edward S. Cole has worked with prominent companies in the biotechnology sector, including Genzyme Transgenics Corporation and GTC Biotherapeutics, Inc. His experience in these organizations has allowed him to advance his research and contribute to the development of groundbreaking therapies.
Collaborations
Some of his notable coworkers include Harry M. Meade and Paul Ditullio. Their collaboration has likely played a role in the success of his innovative projects.
Conclusion
Edward S. Cole's contributions to transgenic technology and his innovative patents have positioned him as a key figure in the biotechnology field. His work continues to influence medical treatments and improve patient outcomes.